📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
3 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
3
RECENT COVERAGE · 4 ARTICLES
Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM)
Insmed (INSM) was added to TimesSquare Capital Management's U.S. Mid Cap Growth Strategy during Q1 2026, signaling selective conviction...
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)
Mizuho Securities adjusted its valuation framework for INSM on June 15, reducing the price target by approximately 5% from $202 to $192...
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
Insmed (INSM) received a modest price target increase from Cantor Fitzgerald, with the analyst firm raising guidance from $230 to $235...
Insmed: Extensive Phase 3 TPIP Program And Revenue Growth In Q1 2026, Strong Buy (INSM)
INSM is advancing multiple clinical and commercial catalysts that support bullish momentum in a niche respiratory therapeutics market....
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice